Literature DB >> 3882117

The glomerular polyanion (GPA) of the rat kidney. III. Further characterization of a vaso-active serum factor which reduces GPA.

W W Bakker, G Roskam, M J Hardonk, J T Vos, E Bleumink.   

Abstract

Fractions of normal rat serum were purified using gel chromatography and their molecular weights were analysed using gradient polyacrylamide gel electrophoresis (PAGE). The fractions were tested for their capacity to affect in vitro glomerular polyanion (GPA) in rat kidney tissue whereas their vascular enhancing capacity in vivo after intradermal injection into the rat skin was analysed. GPA impairment in vitro was estimated after incubation of the fractions with tissue sections for 2 h at 37 degrees C and subsequent staining for sialoproteins with colloidal iron. Enhanced vascular responses were assayed using a standard vascular permeability test in the rat skin. The results show that a factor with an estimated molecular weight of 120 000 was responsible for a dose-related activity in both test systems studied. The activity of this fraction could be inhibited by various plasma kallikrein-inhibiting protease inhibitors, whereas in addition the skin response could be inhibited by pyridinolcarbamate and not by histamine- or serotonin-inhibiting drugs. From the inhibition patterns in vivo and in vitro as well as from the estimated molecular weight of the fraction, it is suggested that a plasma kallikrein-like factor might be responsible for the activities observed. We feel that further study of this fraction in rat or human serum is worthwhile in particular with respect to nephrotic conditions associated with GPA loss.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882117      PMCID: PMC2041028     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  8 in total

1.  Studies on prekallikrein of bovine plasma. I. Purification and properties.

Authors:  H Takahashi; S Nagasawa; T Suzuki
Journal:  J Biochem       Date:  1972-03       Impact factor: 3.387

2.  [Activation of the coagulation and kinin system by a plasma esterase (Hageman factor): purification and conditions of activity].

Authors:  H Temme; R Jahrreiss; E Habermann; F Zilliken
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1969-04

3.  Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis.

Authors:  N L Anderson; N G Anderson
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

4.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

5.  A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.

Authors:  G Lagrue; S Xheneumont; A Branellec; G Hirbec; B Weil
Journal:  Biomedicine       Date:  1975-02-10

6.  Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.

Authors:  M Schapira; C F Scott; R W Colman
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

7.  Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.

Authors:  R C Wiggins; D J Loskutoff; C G Cochrane; J H Griffin; T S Edgington
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

8.  Plasma prekallikrein: isolation, characterization, and mechanism of activation.

Authors:  K D Wuepper; C G Cochrane
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

  8 in total
  2 in total

Review 1.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 2.  An alternative view of the proposed alternative activities of hemopexin.

Authors:  Marcia R Mauk; Ann Smith; A Grant Mauk
Journal:  Protein Sci       Date:  2011-03-30       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.